Clinical Trial Data With Perioperative Therapy in MIBC: Bladder BRIDGister
Expert panelists reflect on the molecular subtyping of patients to predict response to neoadjuvant therapy in Bladder BRIDGister.
Stay updated with breaking news from Molecular Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Expert panelists reflect on the molecular subtyping of patients to predict response to neoadjuvant therapy in Bladder BRIDGister.
The episode underscores Twitter’s importance to political movements and influence efforts across the globe, even as dysfunction has roiled the platform.
Shared insight on best practices in diagnosing patients with differentiated thyroid cancer with a focus on histologic and molecular subtypes.
Opening their discussion on colorectal cancer, expert panelists consider its growing prevalence and highlight key molecular subtypes.
Shared insight on appropriate molecular lab testing options that should be explored following a diagnosis of colorectal cancer.